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Abstract
Patients that present with a periprosthetic joint infection in a single joint
may have multiple prosthetic joints. The risk of these patients developing a
subsequent infection in another prosthetic joint is unknown. Our purposes were (1)
identify the risk of developing a subsequent infection in another prosthetic joint;
and (2) describe the time span, and organism profile to the second prosthetic
infection. We retrospectively identified 55 patients with periprosthetic joint
infection who had another prosthetic joint in place at the time of presentation.
Eleven of the 55 patients (20%) developed a periprosthetic joint infection in a
second joint. The type of organism was the same as the first infection in four of 11
patients (36%). The time to developing a second infection was 2.0 years (range, 06.9 years).

Keywords: Multiple Periprosthetic Joint Infection; Hip Arthroplasty; Knee
Arthroplasty; Risk of subsequent infection; Phenotypically Identical Infecting
Organisms.
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Introduction
Periprosthetic joint infection (PJI) is an important failure mechanism of
implants after either primary or revision total joint arthroplasty (TJA)1-3. It occurs
in approximately 0.2% to 2.5% of primary THAs or TKAs2,4-6. Revision THA or
TKA carries an infection risk of 3.2% to 9%2,3. When PJI develops, an extensive
burden is placed on the affected patient and the treating physician. PJI causes
considerable increase in the cost of health care and increases the rate of morbidity
and mortality2,7.
On occasion, patients presenting with developed PJI have multiple lower
limb prosthetic joints. It is always a concern that the presence of any nidus of
ongoing infection in the body can lead to PJI. Therefore, it is cause for concern
that patients may develop PJI in coexisting, aseptic joints when another joint
becomes infected. To mediate infections, surgeons use methods such as antibiotics,
irrigation and debridement, and antibiotic spacers. In order to help curtail
infection, patients are encouraged to take antibiotics before procedures that are
considered high risk for inducing bacteremia, such as dental procedures. However,
the role of these prophylactic antibiotics is a matter of controversy8,9.
Therefore, we had two objectives: (1) to identify the risk of developing an
additional PJI in a coexisting prosthetic joint; and (2) to describe the time to
additional infection and organism profile of the second prosthetic infection.
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Patients and Methods
We used our joint infection database to identify patients that had confirmed
diagnoses of PJI at our institute from 2000 to 2009. These patients were
crossreferenced with our prospective joint arthroplasty database to identify all
patients who had at least two primary arthroplasties (hip or knee) performed at
this institution and later developed a PJI in at least one. We identified 55 patients.
These patients averaged 63.4 years of age (range: 31-90 years) and 26 of the 55
(47%) were male. The average BMI of these 55 patients was 32.2 kg/m2 (95% CI:
30.1-34.2). Out of the 55 patients, 46 (84%) presented with pertinent
comorbidities (Table 1). Seventeen (30.9%; 17/55%) patients developed a PJI
within a four week period postoperatively, thus indicating an acute onset. The
remaining 38 (%) developed their first incident of PJI within 8.2 years. Nine
(16%) of these patients presented with ipsilateral implants, 37 (67%) were
contralateral knees, 16 (29%) were contralateral hips, and nine (16%) were
contralateral hip and knee. Five patients had three prosthetic joints and two
patients had both hips and both knees replaced. The total number of joints does
not total 55 because of patients who presented with more than two joints replaced.
These patients with three and four joints replaced constitute the discrepancy of the
overall figure and the 55 patients noted (Table 1). Infection was defined as the
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presence of a positive preoperative fluid or intraoperative tissue culture, presence
of purulence, or elevated erythrocyte sedimentation rate, C-reactive protein,
synovial white blood cell, and polymorphonuclear percentage10. Follow-up for
this study is defined as patients that suffered a single PJI while having multiple
TJA in place, who subsequently returned for an additional infection to a second
joint. In this case no patients were lost to follow-up; however, it is possible that
patients retained services for an additional infection elsewhere. No patients were
recalled specifically for this study; all data was obtained from medical records.
We had prior approval of our Institutional Review Board.
To ascertain the rate of infection in a prosthetic joint after development of
PJI in the first joint, the joint infection database at this institution was again used
to identify any subsequent infections in these patients. It was verified that the
subsequent infection cases developed in prosthetic joints that had been replaced
before the development of the first periprosthetic joint infections.
The nature of the second infection was analyzed by noting the duration
between the initial infection and the subsequent infection, and determining the
organism profile for each infection. Organisms of the two infections were
considered identical if they were of identical species and had identical resistance
profiles.
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To ascertain potential predictors of suffering multiple joint PJI in this group
of patients, univariate statistical analysis was performed on potential variables
(Table 1). This included age, BMI, gender, systemic health, and status of joint
replacements. Systemic health was measured with the Deyo et al modification of
the Charlson Index.11 A review of charts was also performed in attempts to
identify specific comorbidities that may contribute to risk of subsequent additional
joint PJI. Statistical analysis consisted of a Student’s t-test for continuous
variables and Chi-squared test for categorical variables. Analysis was performed
using PASW Statistics 18.0.0 (SPSS Incorporated, Chicago, IL).
Results
Of the 55 patients who presented with multiple coexisting prosthetic joints,
with PJI present in at least one, 11 patients (20%) subsequently developed PJI in a
second coexisting prosthetic joint. The second joint infection developed in
contralateral knees in eight (73%) of the 11 patients, contralateral hips in two
(18%) of the 11 patients, and ipsilateral hip and knee in one patient (9%) (Figure
1). The average BMI of these 11 patients was found to be 31.3 kg/m2,
demonstrating no statistical difference when compared to that of the overall
cohort. When comparing specific comorbidities of the patients diagnosed with
multiple infections versus those with a solitary infection no statistical difference
exists. However, when comparing the multiple versus single PJI groups, the
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multiple PJI group had a greater median Charlson Index (4 versus 2.5; p=0.16).
As well, the initial PJI incident was less likely to have occurred in the acute
postoperative setting (less than four weeks) compared to the single PJI group
(9.1% versus 36.4%; p=0.08)
Of these 11 patients that sustained multiple PJIs, four were diagnosed as
having phenotypically identical organisms for both infections. For two of these
patients, the presentation of PJI was simultaneous. The two remaining patients
presented with the second joint infection at 4 months and 3.5 years, respectively
(Figure 2). The time from presentation of the original PJI to the infection in the
second joint averaged 2.0 years (range, 0-6.88 years).

Discussion
Several studies have been performed to find the risk factors for infection
after TJA to decrease the rate of this devastating complication6,8,9,12,13.
Accordingly, several preventive measures have been recommended to decrease the
rate of PJI8,9. However, the authors were unable to find any literature that
addresses the risk of developing synchronous or metachronous PJI. Therefore, we
had two objectives: (1) to identify the risk of developing an additional PJI in a
coexisting prosthetic joint; and (2) to describe the time to additional infection and
organism profile of the second prosthetic infection.

8
Our study has some limitations. First, this investigation is a retrospective
review of a database; the data is input by clerks and as such is subject to clerical
error and/or may be incomplete, rendering a lower yield of complete data set.
Second, despite all efforts to capture all PJI in our institution during the study
time, some patients may have sought medical attention at other institutions in the
event of developing PJI. Finally, despite evaluating all data referring to diagnostic
workup for PJI, some origin or nidus of infection that could have led to a
subsequent PJI may have been missed. This would yield different results in the
mechanism of infection, which is why we refrain ourselves from establishing such
in the article.
We found that 55 patients presented with multiple coexisting prosthetic
joints, in which at least one developed PJI. Eleven patients developed a PJI in a
second coexisting prosthetic joint. Therefore, the relative risk of developing a
synchronic or metachronic PJI is 20%. In patients who did not present with
simultaneous PJI, the time of presentation for metachronic PJI averaged 2.71
years.
This increased risk of developing another PJI appears excessively high
compared even with the highest incidence of isolated PJI reported in the literature.
In our cohort, all patients shared the same preoperative, intraoperative, and
postoperative protocols (prophylactic antibiotic, laminar flow, personal protection
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system, etc), similar hospital stay, and same postoperative rehabilitation regimen.
The fact that some patients with multiple TJA only develop an isolated PJI and
some develop multiple PJI may indicate a host compromise or a reoccurring
exposure despite the similarities in preexisting condition and demographics
between the multiple and single PJI groups. While statistical significance was not
achieved, the large difference in Charlson Index supports the reasoning that
patients who developed multiple PJI have decreased general health contributing to
multiple joint PJI. Supporting this is the observation that a third of single PJI
patients developed PJI within the acute postoperative period, while less than 10%
of multiple PJI patients developed PJI in the acute postoperative period. This
points to a compromised immune system and lower overall health leading to PJI in
the multiple PJI group while surgical contamination appears to be a major factor
in the single PJI group. This would suggest that the risk of multiple infections do
not coincide with presence of multiple joints but rather the associated traits and
actions of the patient.
Four of the 11 patients (36%) with multiple PJI were diagnosed as having
phenotypically identical infecting organisms for both joints (Figure 1); in two of
these patients, the presentation was synchronic, suggesting a hematogenous mode
of infection. In the other two metachronic PJI, host characteristics were most likely
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the cause of multiple infections. In all four of these patients, the involved joints
where contralateral.
This evaluation shows that there is a high risk of developing multiple joint PJI
when patients present with PJI in a single joint and multiple prosthetic joints. It
appears that the risk is elevated in immunocompromised patients suffering chronic
or delayed PJI. Future research is needed to confirm the risk factors identified
here and develop methods for minimizing the risk of multiple joint PJI. Regardless
of the cause, it is evident that there is a significant risk of multiple joint PJI (20%)
and therefore, the surgeon should cautiously investigate any asymptomatic joints
in the face of a single PJI, and alert the patient to the increased risk of subsequent
PJI.
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